Notice ID: d4a89274ddfa4531b5a29fc69d067298Combined Synopsis/Solicitation
Amendment 001_Synthesis Services for Custom Biomolecules for Detection of Mutation-Reactive T cells in Patients With Metastatic Cancers
Archived on September 30, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 6:00 PM UTC−04:00
- Posted
- August 7, 2024
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 621511: Medical Laboratories
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NIH NCI
- Place of performance
- Bethesda, MD, 20892
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- 75N91024Q00094
- Notice ID
- d4a89274ddfa4531b5a29fc69d067298
Description
The purpose of Amendment 001 is to attach PDF "52.212-3(MAY2024)_FullText." Response date remains unchanged. ***Please read the attached documents*** The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Surgery Branch (SB) requires synthesis services for custom biomolecules for the detection of Mutation-Reactive T cells in patients with Metastatic Cancers. This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR 13.5 - Simplified Procedures for Certain Commercial Products and Commercial Services. This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-05 (05/22/2024). One firm fixed priced award is anticipated to be made as a result of this solicitation. Please submit questions concerning this RFQ via email no later than 12:00PM EDT on Thursday, 08/08/2024. Quotes in response to this RFQ must be submitted via email no later than 6:00PM EDT on Monday, 08/12/2024.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N91024Q00094- Combined Synopsis
- 2×Combined SynopsisCurrentAug 6, 2024
Amendment 001_Synthesis Services for Custom Biomolecules for Detection of Mutation-Reactive T cells in Patients With Metastatic Cancers
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N91024Q00094
Archive Date
Sep 30, 2024
Office Address
Bethesda, MD, 20892